Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy.

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 11-4-2026, 19:57